scheduling actions controlled substances regulated chemicals

U.S. Department of Justice Drug Enforcement Administration Diversion Control Division Drug & Chemical Evaluation Section

Lists of:

Scheduling Actions

Controlled Substances

Regulated Chemicals

March 2018

Foreword The first three sections of this booklet list the names of the substances which are described in the Code of Federal

Regulations (CFR) as well as some of those which generate frequent inquiries. The substances are first arranged

alphabetically, then by Drug Enforcement Administration (DEA) drug code number, and finally by Controlled Substances

Act (21 U.S.C. 801 et seq.) (CSA) schedule.

These lists describe the basic or parent chemical and do not describe the salts, isomers, salts of isomers, esters,

ethers, and derivatives which may be controlled substances. These are not comprehensive lists so please note that a

substance need not be listed as a controlled substance to be treated as a scheduled substance for criminal prosecution.

The Other Names column, provides some examples of alternate names for certain compounds, and in some

instances provides examples of positional isomers. If outside parties want to ensure that a compound is not

considered a scheduled substance or listed chemical, they should write the DEA, Drug and Chemical Evaluation

Section (DRE), Diversion Control Division, 8701 Morrissette Drive, Springfield, Virginia 22152, for an official

determination.

A substance (not included on these lists) may also be regulated as a controlled substance analogue. A controlled

substance analogue is a substance which is intended for human consumption, is structurally substantially similar to a schedule

I or schedule II substance, is pharmacologically substantially similar to a schedule I or schedule II substance, or is

represented as being similar to a schedule I or schedule II substance and is not an approved medication in the United States.

See 21 U.S.C. 802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. 813 for the schedule.

The next two sections of this booklet list the Federal Register notices through which the DEA has directed substances

to be added, deleted or transferred between schedules of the CSA. The scheduling changes are listed first in alphabetical

order by substance and then in chronological order by effective date. With the exception of anabolic steroids, section 812 of

the CSA lists only those substances which were controlled in 1970 when the law was enacted. Since then, over 200

substances have been added, removed, or transferred from one schedule to another. The current official list of controlled

substances can be found in section 1308 of the most recent issue of Title 21 Code of Federal Regulations Part 1300 to end (21

CFR 1308) and the final rules which have been published in the Federal Register subsequent to the issuance of the CFR.

The CFR and the Federal Register are available on the U.S. Government Printing Office web site at

https://www.gpo.gov/fdsys/. This information is accessible, also, on the Diversion Control Divisions website at

https://www.deadiversion.usdoj.gov/.

The last section of this booklet identifies the List I and List II chemicals. Certain commercial transactions

involving these chemicals are regulated by the CSA. See 21 CFR 1309, 1310 and 1313 for details.

These lists are intended as general references and are not comprehensive listings of all controlled substances and

regulated chemicals.

Drug and Chemical Evaluation Section Diversion Control Division

Drug Enforcement Administration

Telephone: 202-307-7183 FAX: 202-353-1263

March 2018

http:https://www.deadiversion.usdoj.govhttps://www.gpo.gov/fdsys

Abbreviations

2C-B = 4-Bromo-2,5-dimethoxyphenethylamine

2C-T-7 = 2,5-Dimethoxy-4(n)-propylthiophenethylamine

BZP = N-Benzylpiperazine

DMT = Dimethyltryptamine

DOM = 4-Methyl-2,5-dimethoxyamphetamine

GBL = Gamma butyrolactone

GHB = Gamma hydroxybutyric acid, gamma hydroxybutyrate, 4-hydroxybutanoic acid, sodium oxybate

LAAM = Levo-alphacetylmethadol

LSD = Lysergic acid diethylamide, lysergide

MDA = 3,4-Methylenedioxyamphetamine

MDE = 3,4-Methylenedioxy-N-ethylamphetamine

MDMA = 3,4-Methylenedioxymethamphetamine

MPPP = 1-Methyl-4-phenyl-4-propionoxypiperidine

P2P = Phenyl-2-propanone, phenylacetone

PCC = 1-Piperidinocyclohexanecarbonitrile

PCE = N-Ethyl-1-phenylcyclohexylamine

PCH = 1-Phenylcyclohexylamine

PCP = 1-(1-Phenylcyclohexyl)piperidine, phencyclidine

PEPAP = 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine

PHP = 1-(1-Phenylcyclohexyl)pyrrolidine

SPA = (-)-1-Dimethylamino-1,2-diphenylethane

TCP = 1-[1-(2-Thienyl)cyclohexyl]piperidine

TCPy = 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine

THC = Tetrahydrocannabinols

THG = Tetrahydrogestrinone

Scheduling Actions A

lphabetical Order

Scheduling Actions

- Alphabetical Order -

FINAL ORDER

SUBSTANCE PROPOSAL FEDERAL *Scheduled under 21 USC 811(h) PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA **Extension of temporary control DATE DATE CITATION DATE SCHEDULE

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)*

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3- 01-30-15 80 FR 5042 1/30/2015 I YL](NAPHTHALEN-1-YL)METHANONE (THJ-2201)*

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR-144, XLR11)*

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) 09-08-03 03-18-04 69 FR 12794 3/19/2004 I --> 0

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) * 09-20-02 67 FR 59161 9/20/2002 I

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) ** 09-10-03 68 FR 53289 9/20/2003 I

1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE 03-20-89 07-06-89 54 FR 28414 7/6/1989 I

19-NOR-4,9(10)-ANDROSTADIENEDIONE (estra-4,9(10)-diene- 04-25-08 12-04-09 74 FR 63603 1/4/2010 III 3,17-dione)

2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL) ETHANAMINE (25B-NBOMe)*

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL) ETHANAMINE (25C-NBOMe)*

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe)*

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-08-03 03-18-04 69 FR 12794 3/18/2004 I T-7)

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-20-02 67 FR 59163 9/20/2002 I T-7) *

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-10-03 68 FR 53289 9/20/2003 I T-7) **

2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET) 10-30-87 01-14-93 58 FR 4316 2/16/1993 I

2,5-DIMETHOXYAMPHETAMINE (DMA) 05-31-73 09-21-73 38 FR 26447 9/21/1973 I

3,4-DICHLORO-N-[(1- 04-14-16 81 FR 22023 5/15/2016 I DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE) (AH-7921)

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 11-14-16 81 FR 79389 11/14/2016 I METHYLBENZAMIDE (U-47700)*

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE)

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 76 FR 65371 10/21/2011 I (METHYLONE)*

3,4-METHYLENEDIOXYPYROVALERONE (MDPV)* 10-21-11 76 FR 65371 10/21/2011 I

3-FLUORO-N-METHYLCATHINONE (3-FMC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

3-FLUORO-N-METHYLCATHINONE (3-FMC)* 03-07-14 79 FR 12938 3/7/2014 I

Scheduling Actions - Alphabetical Order

01-Mar-18 Page 1 of 10

SUBSTANCE

*Scheduled under 21 USC 811(h)

**Extension of temporary control

PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

3-FLUORO-N-METHYLCATHINONE (3-FMC)** 03-04-16 81 FR 11429 3/4/2016 I

3-METHYLFENTANYL 04-24-86 09-22-86 51 FR 33592 9/22/1986 I

3-METHYLFENTANYL* 03-25-85 50 FR 11690 4/25/1985 I

3-METHYLFENTANYL** 04-24-86 51 FR 15474 4/25/1986 I

3-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

3-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

3-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP) 04-09-08 06-29-10 75 FR 37296 8/30/2010 II

4-BROMO-2,5-DIMETHOXYAMPHETAMINE 07-02-73 09-21-73 38 FR 26447 9/21/1973 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE 12-20-94 06-02-95 60 FR 28718 6/2/1995 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE* 01-06-94 59 FR 00671 1/6/1994 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE** 12-21-94 59 FR 65710 1/6/1995 I



4-FLUORO-N-METHYLCATHINONE (4-FMC)** 03-04-16 81 FR 11429 3/4/2016 I

4-METHOXYAMPHETAMINE (PMA) 07-02-73 09-21-73 38 FR 26447 9/21/1973 I

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 03-01-17 82 FR 12171 3/1/2017 I MePPP)

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-07-14 79 FR 12938 3/7/2014 I MePPP)*

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 81 FR 11429 3/4/2016 I MePPP)**

4-METHYLAMINOREX 10-14-88 04-13-89 54 FR 14799 4/13/1989 I

4-METHYLAMINOREX* 10-15-87 52 FR 38225 10/15/1987 I

4-METHYLAMINOREX** 10-13-88 53 FR 40061 10/13/1988 I

4-METHYL-N-ETHYLCATHINONE (4-MEC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

4-METHYL-N-ETHYLCATHINONE (4-MEC)* 03-07-14 79 FR 12938 3/7/2014 I

4-METHYL-N-ETHYLCATHINONE (4-MEC)** 03-04-16 81 FR 11429 3/4/2016 I

4-METHYL-N-METHYLCATHINONE (MEPHEDRONE)* 10-21-11 76 FR 65371 10/21/2011 I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 09-29-04 69 FR 58050 9/29/2004 I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) * 04-04-03 68 FR 16427 4/4/2003 I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 04-01-04 69 FR 17034 4/1/2004 I **

5-METHOXY-N,N-DIMETHYLTRYPTAMINE 08-21-09 12-20-10 75 FR 79296 1/19/2011 I

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 06-07-17 82 FR 26349 6/7/2017 I PHENYLACETAMIDE)

ACETYL FENTANYL* (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-17-15 80 FR 42381 7/17/2015 I PHENYLACETAMIDE)

ACETYL-ALPHA-METHYLFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

ACETYL-ALPHA-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

ACETYL-ALPHA-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-14-17 82 FR 32453 7/14/2017 I PHENYLACRYLAMIDE)*

ALFAXALONE (5-PREGNAN-3-OL-11,20-DIONE) 03-25-13 02-27-14 79 FR 10985 3/31/2014 IV



FINAL ORDER


ALFENTANIL 04-17-86 01-23-87 52 FR 2516 1/23/1987 I -> II

ALFENTANIL 06-25-84 49 FR 25849 8/24/1984 I

ALPHA-ETHYLTRYPTAMINE 03-07-94 09-12-94 59 FR 46757 9/12/1994 I

ALPHA-ETHYLTRYPTAMINE* 03-12-93 58 FR 13533 3/12/1993 I

ALPHA-ETHYLTRYPTAMINE** 03-07-94 59 FR 10720 3/12/1994 I

ALPHA-METHYLFENTANYL 08-05-81 09-22-81 46 FR 46799 9/22/1981 I

ALPHA-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

ALPHA-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

ALPHA-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

ALPHA-METHYLTRYPTAMINE (AMT) 09-29-04 69 FR 58050 9/29/2004 I

ALPHA-METHYLTRYPTAMINE (AMT) * 04-04-03 68 FR 16427 4/4/2003 I

ALPHA-METHYLTRYPTAMINE (AMT) ** 04-01-04 69 FR 17034 4/1/2004 I

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP)* 03-07-14 79 FR 12938 3/7/2014 I

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP)** 03-04-16 81 FR 11429 3/4/2016 I

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP)* 03-07-14 79 FR 12938 3/7/2014 I

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP)** 03-04-16 81 FR 11429 3/4/2016 I

ALPRAZOLAM 04-29-81 11-12-81 46 FR 55688 11/12/1981 IV

AMINOREX 08-20-93 03-18-94 59 FR 12828 3/18/1994 I

AMINOREX* 09-21-92 57 FR 43399 9/21/1992 I

AMINOREX** 08-24-93 58 FR 44611 9/21/1993 I

AMOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III -> II

AMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III -> II

ANABOLIC STEROIDS PL 108-358 12-16-05 70 FR 74653 1/17/2006 III


APOMORPHINE 04-08-76 06-28-76 41 FR 26568 6/28/1976 II -> 0

BENZPHETAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

BENZYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

BETA-HYDROXY-3-METHYLFENTANYL 11-28-86 01-08-88 53 FR 500 1/8/1988 I

BETA-HYDROXY-3-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

BETA-HYDROXY-3-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I Expired 5/29/87

BETA-HYDROXYFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

BETA-HYDROXYFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

BETA-HYDROXYFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

BETA-HYDROXYTHIOFENTANYL* 05-12-16 81 FR 29492 5/12/2016 I

BIPHETAMINE & BIPHETAMINE-T 05-26-71 07-23-71 36 FR 13686 7/23/1971 III -> II

BOLDIONE (Androsta-1,4-diene-3,17-dione) 04-25-08 12-04-09 74 FR 63603 1/4/2010 III

BRIVARACETAM (BRV; UCB-34714; BRIVIACT) 05-12-16 81 FR 29487 5/12/2016 V



SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

BROMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

BUPRENORPHINE 03-21-02 10-07-02 67 FR 62354 10/7/2002 V --> III

BUPRENORPHINE 09-20-82 02-28-85 50 FR 8104 4/1/1985 II -> V

BUTORPHANOL 07-10-97 10-01-97 62 FR 51370 10/31/1997 IV

BUTORPHANOL, THEBAINE DERIVED 04-03-92 07-14-92 57 FR 31126 7/14/1992 II->0 Supersede

d 10/97

BUTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

BUTYLONE* 03-07-14 79 FR 12938 3/7/2014 I

BUTYLONE** 03-04-16 81 FR 11429 3/4/2016 I

BUTYRYL FENTANYL* 05-12-16 81 FR 29492 5/12/2016 I

CAMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CARFENTANIL 01-12-88 10-28-88 53 FR 43684 10/28/1988 II

CARISOPRODOL 11-17-09 12-12-11 76 FR 77330 1/11/2012 IV

CATHINE 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

CATHINONE 10-30-87 01-14-93 58 FR 4316 2/16/1993 I

CHLORDIAZEPOXIDE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

CHLORPHENTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

CLOBAZAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CLONAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

CLORAZEPATE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

CLORTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

CLOTIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CLOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CONCENTRATE OF POPPY STRAW 12-20-74 02-14-75 40 FR 6779 2/14/1975 II

CP-47,497 * 03-01-11 76 FR 11075 3/1/2011 I

CP-47,497 ** 02-29-12 77 FR 12201 2/29/2012 I

CP-47,497 C8 HOMOLOGUE * 03-01-11 76 FR 11075 3/1/2011 I

CP-47,497 C8 HOMOLOGUE ** 02-29-12 77 FR 12201 2/29/2012 I

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 01-04-18 83 FR 469 1/4/2018 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)*

DELORAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

DESOXYMETHYLTESTOSTERONE (17a-methyl-5a-androst-2- 04-25-08 12-04-09 74 FR 63603 1/4/2010 III en-17-ol, madol)

DEXTROPROPOXYPHENE 01-21-80 06-24-80 45 FR 42264 7/24/1980 IV


DEXTROPROPOXYPHENE (BULK) 07-22-80 45 FR 48881 9/22/1980 IV -> II

DEXTRORPHAN 04-19-76 10-01-76 41 FR 43401 10/1/1976 I -> 0

DIAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

DICHLORALPHENAZONE (chloral hydrate compound) 12-11-00 08-16-01 66 FR 42943 8/16/2001 clarification of CIV control

DIETHYLPROPION 05-10-73 07-06-73 38 FR 18013 7/6/1973 IV



FINAL ORDER


DIFENOXIN 05-07-75 40 FR 19813 6/1/1975 I

DIFENOXIN 1 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I -> IV

DIFENOXIN 1/2 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I -> V

DIHYDROETORPHINE (thebaine derivative) 11-17-00 65 FR 69442 11/17/2000 clarification of CII control

DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT 03-23-17 82 FR 14815 3/23/2017 II APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMIN.

DRONABINOL PRODUCT (MARINOL) 11-05-98 07-02-99 64 FR 35928 7/2/1999 II -> III

DRONABINOL PRODUCT (MARINOL) 10-18-85 05-13-86 51 FR 17476 5/13/1986 I -> II

DROTEBANOL 07-03-73 38 FR 17717 8/6/1973 I

ELUXADOLINE 08-11-15 11-12-15 80 FR 69861 12/17/2015 IV

EMBUTRAMIDE 07-29-05 08-29-06 71 FR 51115 9/28/2006 III

ESKATROL 05-26-71 08-18-71 36 FR 15744 8/18/1971 III -> II

ESTAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

ETHYL LOFLAZEPATE 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

ETORPHINE HYDROCHLORIDE 11-23-73 03-29-74 39 FR 11535 4/19/1974 I -> II

EZOGABINE 10-21-11 12-15-11 76 FR 77895 12/15/2011 V

FENCAMFAMIN 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

FENETHYLLINE 05-01-81 07-21-81 46 FR 37503 8/20/1981 I

FENFLURAMINE 05-15-03 68 FR 26247 5/15/2003 IV Withdrew

97 proposed

rule

FENFLURAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 IV

FENFLURAMINE 05-06-97 05-06-97 5/6/1997 IV -> 0

FENPROPOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 02-06-18 83 FR 5188 2/6/2018 I CFR 1308.11(h)*

FETAMIN 05-26-71 07-23-71 36 FR 13686 7/23/1971 III -> II

FLUDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

FLUNITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

FLURAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

FOSPROPOFOL 07-23-09 10-06-09 74 FR 51234 11/5/2009 IV

FUBAMB, MMB FUBINACA (2-(1-(4-FLUOROBENZYL)- 11-03-17 82 FR 51154 11/3/2017 I 1HINDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE*

GAMMA HYDROXYBUTYRIC ACID (GHB) PL 106-172 03-13-00 65 FR 13235 3/13/2000 I

GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug PL 106-172 03-13-00 65 FR 13235 3/13/2000 III products

GLUTETHIMIDE 07-26-90 03-21-91 56 FR 11930 3/21/1991 III -> II

HALAZEPAM 04-29-81 10-29-81 46 FR 53407 10/29/1981 IV

HALOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

HYDROCODONE COMBINATION PRODUCTS 02-27-14 08-22-14 79 FR 49661 10/6/2014 III->II



FINAL ORDER


INDIPLON 01-31-08 01-31-08 1/31/2008 IV

JWH-018 * 03-01-11 76 FR 11075 3/1/2011 I

JWH-018 ** 02-29-12 77 FR 12201 2/29/2012 I

JWH-073 * 03-01-11 76 FR 11075 3/1/2011 I

JWH-073 ** 02-29-12 77 FR 12201 2/29/2012 I

JWH-200 * 03-01-11 76 FR 11075 3/1/2011 I

JWH-200 ** 02-29-12 77 FR 12201 2/29/2012 I

KETAMINE 04-09-99 07-13-99 64 FR 37673 8/12/1999 III

KETAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

LACOSAMIDE 03-10-09 05-21-09 74 FR 23789 6/22/2009 V

LEVO-ALPHACETYLMETHADOL (LAAM) 04-28-93 08-18-93 58 FR 43795 8/18/1993 I -> II

LIBRAX 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

LISDEXAMFETAMINE 02-22-07 05-03-07 72 FR 24532 6/4/2007 II

LOPERAMIDE 07-28-82 11-03-82 47 FR 49840 11/3/1982 V -> 0

LOPERAMIDE 07-29-76 05-18-77 42 FR 25498 6/17/1977 V

LOPRAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

LORAZEPAM 06-28-77 10-07-77 42 FR 54546 10/3/1977 IV

LORCASERIN 12-19-12 05-08-13 78 FR 26701 6/7/2013 IV

LORMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

MAZINDOL 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

MAZINDOL 04-17-81 10-27-81 46 FR 52333 11/27/1981 III -> IV

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 02-22-88 53 FR 5156 3/23/1988 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 01-27-88 53 FR 2225 1/27/1988 I -> 0

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 07-27-84 10-14-86 51 FR 36552 11/13/1986 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)* 05-31-85 50 FR 23118 7/1/1985 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)** 06-17-86 51 FR 21911 7/1/1986 I

MEBUTAMATE 12-13-74 01-30-75 40 FR 4418 1/30/1975 IV

MECLOQUALONE 05-29-75 07-08-75 40 FR 28611 7/10/1975 I

MEDAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

MEFENOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

MENRIUM 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

METHAMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III -> II

METHAQUALONE 08-27-84 49 FR 33870 8/27/1984 II -> I

METHAQUALONE 04-11-73 10-04-73 38 FR 27516 10/4/1973 II

METHASTERONE ( 2 ALPHA-17 ALPHA-DIMETHYL-5 ALPHA- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III ANDROSTAN-17BETA-OL-3-ONE)

METHCATHINONE 04-28-93 10-15-93 58 FR 53404 10/15/1993 I

METHCATHINONE* 05-01-92 57 FR 18824 5/1/1992 I

METHCATHINONE** 04-29-93 58 FR 25934 5/1/1993 I



FINAL ORDER

SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FEDERAL

REGISTER

CITATION EFFECTIVE

DATE

CSA

SCHEDULE

METHOXYACETYL FENTANYL (2-METHOXY-N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)*

10-26-17 82 FR 49504 10/26/2017 I

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBFUBINACA)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB-CHMICA)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)*

04-10-17 82 FR 17119 4/10/2017 I

METHYLPHENIDATE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III -> II

MIDAZOLAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV

MODAFINIL 04-14-98 01-27-99 64 FR 4050 1/27/1999 IV

MPPP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I

MPPP* 07-10-85 50 FR 28098 8/12/1985 I

MPPP** 08-11-86 51 FR 28695 8/12/1986 I

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (APINACA, AKB48)*

05-16-13 78 FR 28735 5/16/2013 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)1H-INDAZOLE-3-CARBOXAMIDE (ADBFUBINACA)*

04-10-17 82 FR 17119 4/10/2017 I

N-(1-AMINO-3,3DIMETHYL-1-OXOBUTAN-2-YL)1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3CARBOXAMIDE (MAB-CHMINACA)*

02-05-16 81 FR 6171 2/5/2016 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)*

02-10-14 79 FR 7577 2/10/2014 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)**

02-05-16 81 FR 6175 2/5/2016 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

09-06-16 81 FR 61130 9/6/2016 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (AB-PINACA)*

01-30-15 80 FR 5042 1/30/2015 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)1-(CYCLOHEXYLMETHYL) 1H-INDAZOLE-3-CARBOXAMIDE (AB-CHMINACA)*

01-30-15 80 FR 5042 1/30/2015 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE FUBINACA)**

(AB-02-05-16 81 FR 6175 2/5/2016 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE FUBINACA)*

(AB-02-10-14 79 FR 7577 2/10/2014 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB-FUBINACA)

09-06-16 81 FR 61130 9/6/2016 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2-CARBOXAMIDE (FURANYL FENTANYL) *

11-29-16 81 FR 85873 11/29/2016 I



FINAL ORDER


N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)*

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 02-01-18 83 FR 4580 2/1/2018 I (VALERYL FENTANYL)*

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 02-01-18 83 FR 4580 2/1/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)*

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)*

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)*

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 05-03-17 82 FR 20544 5/3/2017 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)*

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)*

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-10-17 82 FR 17119 4/10/2017 I 3-CARBOXAMIDE (5FAPINACA, 5FAKB48)*

N,N-DIMETHYLAMPHETAMINE 08-02-89 02-02-90 55 FR 3586 2/2/1990 I

N,N-DIMETHYLAMPHETAMINE* 08-03-88 53 FR 29232 8/3/1988 I

N,N-DIMETHYLAMPHETAMINE** 08-02-89 54 FR 31815 8/2/1989 I

NABILONE 06-18-86 04-07-87 52 FR 11042 4/7/1987 II

NALBUPHINE 05-11-76 10-01-76 41 FR 43401 10/1/1976 II -> 0

NALMEFENE 05-31-85 11-04-85 50 FR 45815 11/4/1985 II -> 0

NALOXEGEL 10-29-14 01-23-15 80 FR 3468 1/23/2015 II->0

NALOXONE 07-10-74 12-24-74 39 FR 44392 12/24/1974 II -> 0

NALOXONE HYDROCHLORIDE 08-19-71 09-29-71 36 FR 19116 9/29/1971 II -> 0

NALTREXONE 12-09-74 03-06-75 40 FR 10455 3/6/1975 II -> 0

NAPHYRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

NAPHYRONE* 03-07-14 79 FR 12938 3/7/2014 I

NAPHYRONE** 03-04-16 81 FR 11429 3/4/2016 I

N-BENZYLPIPERAZINE (BZP) 09-08-03 03-18-04 69 FR 12794 3/18/2004 I

N-BENZYLPIPERAZINE (BZP) * 09-20-02 67 FR 59161 9/20/2002 I

N-BENZYLPIPERAZINE (BZP) ** 09-10-03 68 FR 53289 9/20/2003 I

N-ETHYLAMPHETAMINE 09-10-81 12-08-81 46 FR 59969 1/7/1982 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I

NIMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

NITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

NORDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

ORIPAVINE 09-24-07 72 FR 54208 9/24/2007 II

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-26-17 82 FR 49504 10/26/2017 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))*

OXAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

OXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV



SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

PARA-FLUOROFENTANYL 03-10-87 05-29-87 52 FR 20070 5/29/1987 I

PARA-FLUOROFENTANYL* 02-07-86 51 FR 4722 3/10/1986 I

PARA-FLUOROFENTANYL** 03-10-87 52 FR 7270 3/10/1987 I

PARAHEXYL 08-05-82 11-22-82 47 FR 52432 12/22/1982 I

PCC (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II

PCE (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I

PCH (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II

PEMOLINE 11-07-74 01-28-75 40 FR 4150 1/28/1975 IV

PENTAZOCINE 09-13-78 01-10-79 44 FR 2169 2/9/1979 IV

PENTEDRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

PENTEDRONE* 03-07-14 79 FR 12938 3/7/2014 I

PENTEDRONE** 03-04-16 81 FR 11429 3/4/2016 I

PENTOBARBITAL 05-31-75 11-13-73 38 FR 31310 11/13/1973 III -> II

PENTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

PENTYLONE* 03-07-14 79 FR 12938 3/7/2014 I

PENTYLONE** 03-04-16 81 FR 11429 3/4/2016 I

PEPAP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I

PEPAP* 07-10-85 50 FR 28098 8/12/1985 I

PEPAP** 08-11-86 51 FR 28695 8/12/1986 I

PERAMPANEL [2-(2-OXO-1-PHENYL- 10-22-13 12-02-13 78 FR 72013 1/2/2014 III 5-PYRIDIN-2-YL-l ,2-DIHYDROPYRIDIN-3-YL)BENZONITRILE ]

PHENCYCLIDINE (PCP) 12-19-77 01-25-78 43 FR 3359 2/24/1978 III -> II

PHENDIMETRAZINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

PHENMETRAZINE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III -> II

PHENTERMINE 05-09-73 07-06-73 38 FR 18013 7/6/1973 IV

PHENYLACETONE (P2P) 12-12-79 44 FR 71822 2/11/1980 II

PHP (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I

PINAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

PIPRADROL 09-30-80 45 FR 64570 12/1/1980 IV

PRAZEPAM 07-29-76 12-17-76 41 FR 55176 12/17/1976 IV

PREGABALIN 05-12-05 07-28-05 70 FR 43633 7/28/2005 V

PROPIRAM 01-29-72 37 FR 1468 1/29/1972 I

PROPYLHEXEDRINE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V

PROPYLHEXEDRINE 12-03-91 56 FR 61372 12/3/1991 V -> 0

PROSTANOZOL (17 BETA-HYDROXY-5 ALPHA- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III ANDROSTANO[3,2-C]PRYAZOLE

PYROVALERONE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V

QUAZEPAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-10-14 79 FR 7577 2/10/2014 I CARBOXYLATE ( 5-FLUORO-PB22; 5FPB22)*

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-05-16 81 FR 6175 2/5/2016 I CARBOXYLATE ( 5-FLUORO-PB22; 5FPB22)**



SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

09-06-16 81 FR 61130 9/6/2016 I

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-05-16 81 FR 6175 2/5/2016 I (PB22; QUPIC)**

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB22; QUPIC)*

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB- 09-06-16 81 FR 61130 9/6/2016 I 22; QUPIC)

REMIFENTANIL 09-16-96 11-05-96 61 FR 56893 11/5/1996 II

SECOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III -> II

SIBUTRAMINE 12-08-97 02-11-98 63 FR 6862 2/11/1998 IV

SPA (LEFETAMINE) 09-30-80 45 FR 64570 12/1/1980 IV

SUFENTANIL 03-20-84 05-25-84 49 FR 22074 5/25/1984 I -> II

SUFENTANIL 09-30-80 45 FR 64571 12/1/1980 I

SUVOREXANT 02-13-14 08-28-14 79 FR 52143 9/29/2014 IV

TAPENTADOL 02-17-09 05-21-09 74 FR 23790 6/22/2009 II

TCP (PCP ANALOG) 05-29-75 07-08-75 40 FR 28611 8/11/1975 I

TEMAZEPAM 01-05-81 04-07-81 45 FR 20671 4/7/1981 IV

TETRAHYDROFURANYL FENTANYL (N-(1- 10-26-17 82 FR 49504 10/26/2017 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)*

TETRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

THENYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

THIAFENTANIL 08-26-16 81 FR 58834 8/26/2016 II

THIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

THIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

THIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

TILETAMINE/ZOLAZEPAM (TELAZOL) 08-11-86 01-21-87 52 FR 2221 2/20/1987 III

TILIDINE 09-30-80 45 FR 64571 1/12/1980 I

TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3- 11-04-13 07-02-14 79 FR 37623 8/18/2014 IV METHOXYPHENYL)CYCLOHEXANOL)

TRIAZOLAM 04-29-81 12-28-82 47 FR 57694 12/28/1982 IV

ZALEPLON 05-05-99 09-15-99 64 FR 49982 9/15/1999 IV

ZOLPIDEM 11-24-92 02-05-93 58 FR 7186 2/5/1993 IV

ZOPICLONE 02-14-05 04-04-05 70 FR 16935 4/4/2005 IV


01-Mar-18 Page 10 of 10

Scheduling Actions C

hronological Order

Scheduling Actions

- Chronological Order -

FINAL ORDER


AMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III -> II

METHAMPHETAMINE 05-26-71 07-07-71 36 FR 12734 7/7/1971 III -> II

FETAMIN 05-26-71 07-23-71 36 FR 13686 7/23/1971 III -> II

BIPHETAMINE & BIPHETAMINE-T 05-26-71 07-23-71 36 FR 13686 7/23/1971 III -> II

ESKATROL 05-26-71 08-18-71 36 FR 15744 8/18/1971 III -> II

NALOXONE HYDROCHLORIDE 08-19-71 09-29-71 36 FR 19116 9/29/1971 II -> 0

METHYLPHENIDATE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III -> II

PHENMETRAZINE 09-17-71 10-28-71 36 FR 20686 10/28/1971 III -> II

PROPIRAM 01-29-72 37 FR 1468 1/29/1972 I

MAZINDOL 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

PHENDIMETRAZINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

CLORTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

CHLORPHENTERMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

BENZPHETAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 III

FENFLURAMINE 05-09-73 06-15-73 38 FR 15719 6/15/1973 IV

PHENTERMINE 05-09-73 07-06-73 38 FR 18013 7/6/1973 IV

DIETHYLPROPION 05-10-73 07-06-73 38 FR 18013 7/6/1973 IV

DROTEBANOL 07-03-73 38 FR 17717 8/6/1973 I

4-METHOXYAMPHETAMINE (PMA) 07-02-73 09-21-73 38 FR 26447 9/21/1973 I

4-BROMO-2,5-DIMETHOXYAMPHETAMINE 07-02-73 09-21-73 38 FR 26447 9/21/1973 I

2,5-DIMETHOXYAMPHETAMINE (DMA) 05-31-73 09-21-73 38 FR 26447 9/21/1973 I

METHAQUALONE 04-11-73 10-04-73 38 FR 27516 10/4/1973 II

PENTOBARBITAL 05-31-75 11-13-73 38 FR 31310 11/13/1973 III -> II

SECOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III -> II

AMOBARBITAL 05-31-73 11-13-73 38 FR 31310 11/13/1973 III -> II

ETORPHINE HYDROCHLORIDE 11-23-73 03-29-74 39 FR 11535 4/19/1974 I -> II

NALOXONE 07-10-74 12-24-74 39 FR 44392 12/24/1974 II -> 0

PEMOLINE 11-07-74 01-28-75 40 FR 4150 1/28/1975 IV

MEBUTAMATE 12-13-74 01-30-75 40 FR 4418 1/30/1975 IV

CONCENTRATE OF POPPY STRAW 12-20-74 02-14-75 40 FR 6779 2/14/1975 II

NALTREXONE 12-09-74 03-06-75 40 FR 10455 3/6/1975 II -> 0

DIFENOXIN 05-07-75 40 FR 19813 6/1/1975 I

Scheduling Actions - Chronological Order


SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

CLORAZEPATE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

FLURAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

DIAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

CHLORDIAZEPOXIDE 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

OXAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

CLONAZEPAM 01-27-75 06-04-75 40 FR 23998 7/2/1975 IV

MECLOQUALONE 05-29-75 07-08-75 40 FR 28611 7/10/1975 I

TCP (PCP ANALOG) 05-29-75 07-08-75 40 FR 28611 8/11/1975 I

MENRIUM 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

LIBRAX 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

APOMORPHINE 04-08-76 06-28-76 41 FR 26568 6/28/1976 II -> 0

NALBUPHINE 05-11-76 10-01-76 41 FR 43401 10/1/1976 II -> 0

DEXTRORPHAN 04-19-76 10-01-76 41 FR 43401 10/1/1976 I -> 0

PRAZEPAM 07-29-76 12-17-76 41 FR 55176 12/17/1976 IV


LOPERAMIDE 07-29-76 05-18-77 42 FR 25498 6/17/1977 V

LORAZEPAM 06-28-77 10-07-77 42 FR 54546 10/3/1977 IV

PHENCYCLIDINE (PCP) 12-19-77 01-25-78 43 FR 3359 2/24/1978 III -> II

PCC (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II

PCH (PCP PRECURSOR) 03-20-78 05-17-78 43 FR 21324 6/16/1978 II

DIFENOXIN 1/2 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I -> V

DIFENOXIN 1 MG WITH ATROPINE 06-26-78 08-28-78 43 FR 38382 9/27/1978 I -> IV

PHP (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I

PCE (PCP ANALOG) 08-11-78 09-25-78 43 FR 43295 10/25/1978 I

PENTAZOCINE 09-13-78 01-10-79 44 FR 2169 2/9/1979 IV

TILIDINE 09-30-80 45 FR 64571 1/12/1980 I

PHENYLACETONE (P2P) 12-12-79 44 FR 71822 2/11/1980 II


DEXTROPROPOXYPHENE (BULK) 07-22-80 45 FR 48881 9/22/1980 IV -> II

PIPRADROL 09-30-80 45 FR 64570 12/1/1980 IV

SPA (LEFETAMINE) 09-30-80 45 FR 64570 12/1/1980 IV

SUFENTANIL 09-30-80 45 FR 64571 12/1/1980 I

TEMAZEPAM 01-05-81 04-07-81 45 FR 20671 4/7/1981 IV

FENETHYLLINE 05-01-81 07-21-81 46 FR 37503 8/20/1981 I

ALPHA-METHYLFENTANYL 08-05-81 09-22-81 46 FR 46799 9/22/1981 I

HALAZEPAM 04-29-81 10-29-81 46 FR 53407 10/29/1981 IV

ALPRAZOLAM 04-29-81 11-12-81 46 FR 55688 11/12/1981 IV



FINAL ORDER


MAZINDOL 04-17-81 10-27-81 46 FR 52333 11/27/1981 III -> IV

N-ETHYLAMPHETAMINE 09-10-81 12-08-81 46 FR 59969 1/7/1982 I

LOPERAMIDE 07-28-82 11-03-82 47 FR 49840 11/3/1982 V -> 0

PARAHEXYL 08-05-82 11-22-82 47 FR 52432 12/22/1982 I

TRIAZOLAM 04-29-81 12-28-82 47 FR 57694 12/28/1982 IV

SUFENTANIL 03-20-84 05-25-84 49 FR 22074 5/25/1984 I -> II

ALFENTANIL 06-25-84 49 FR 25849 8/24/1984 I

METHAQUALONE 08-27-84 49 FR 33870 8/27/1984 II -> I

ESTAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

LORMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

MEDAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

BROMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

HALOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CLOBAZAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CLOTIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CLOXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

LOPRAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

NORDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

OXAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

FLUNITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

KETAZOLAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

PINAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

CAMAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

NITRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

NIMETAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

ETHYL LOFLAZEPATE 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

FLUDIAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

DELORAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

TETRAZEPAM 08-01-84 10-05-84 49 FR 39307 11/5/1984 IV

BUPRENORPHINE 09-20-82 02-28-85 50 FR 8104 4/1/1985 II -> V

3-METHYLFENTANYL* 03-25-85 50 FR 11690 4/25/1985 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)* 05-31-85 50 FR 23118 7/1/1985 I

MPPP* 07-10-85 50 FR 28098 8/12/1985 I

PEPAP* 07-10-85 50 FR 28098 8/12/1985 I

NALMEFENE 05-31-85 11-04-85 50 FR 45815 11/4/1985 II -> 0

BETA-HYDROXY-3-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

BETA-HYDROXYFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

THIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I



FINAL ORDER


BENZYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

3-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

ALPHA-METHYLTHIOFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

ACETYL-ALPHA-METHYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I

THENYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

PARA-FLUOROFENTANYL* 02-07-86 51 FR 4722 3/10/1986 I

QUAZEPAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV

MIDAZOLAM 02-07-86 03-25-86 51 FR 10190 3/25/1986 IV

3-METHYLFENTANYL** 04-24-86 51 FR 15474 4/25/1986 I

DRONABINOL PRODUCT (MARINOL) 10-18-85 05-13-86 51 FR 17476 5/13/1986 I -> II

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)** 06-17-86 51 FR 21911 7/1/1986 I

PEPAP** 08-11-86 51 FR 28695 8/12/1986 I

MPPP** 08-11-86 51 FR 28695 8/12/1986 I

3-METHYLFENTANYL 04-24-86 09-22-86 51 FR 33592 9/22/1986 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 07-27-84 10-14-86 51 FR 36552 11/13/1986 I

ACETYL-ALPHA-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

3-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

BETA-HYDROXYFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

BETA-HYDROXY-3-METHYLFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I Expired 5/29/87

ALPHA-METHYLTHIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

THIOFENTANYL** 11-26-86 51 FR 42834 11/29/1986 I

MPPP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I

PEPAP 08-11-86 01-23-87 52 FR 2515 1/23/1987 I

ALFENTANIL 04-17-86 01-23-87 52 FR 2516 1/23/1987 I -> II

TILETAMINE/ZOLAZEPAM (TELAZOL) 08-11-86 01-21-87 52 FR 2221 2/20/1987 III

PARA-FLUOROFENTANYL** 03-10-87 52 FR 7270 3/10/1987 I

NABILONE 06-18-86 04-07-87 52 FR 11042 4/7/1987 II

ALPHA-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

BETA-HYDROXYFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

3-METHYLTHIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

ACETYL-ALPHA-METHYLFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

PARA-FLUOROFENTANYL 03-10-87 05-29-87 52 FR 20070 5/29/1987 I

THIOFENTANYL 11-28-86 05-29-87 52 FR 20070 5/29/1987 I

4-METHYLAMINOREX* 10-15-87 52 FR 38225 10/15/1987 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE* 10-15-87 52 FR 38225 10/15/1987 I


Page 4 of 11 01-Mar-18

FINAL ORDER


BETA-HYDROXY-3-METHYLFENTANYL 11-28-86 01-08-88 53 FR 500 1/8/1988 I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 01-27-88 53 FR 2225 1/27/1988 I -> 0

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) 02-22-88 53 FR 5156 3/23/1988 I

PYROVALERONE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V

PROPYLHEXEDRINE 10-30-87 04-04-88 53 FR 10869 5/4/1988 V

CATHINE 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

FENCAMFAMIN 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

FENPROPOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

MEFENOREX 10-30-87 05-17-88 53 FR 17459 6/16/1988 IV

N,N-DIMETHYLAMPHETAMINE* 08-03-88 53 FR 29232 8/3/1988 I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE** 10-13-88 53 FR 40061 10/13/1988 I

4-METHYLAMINOREX** 10-13-88 53 FR 40061 10/13/1988 I

CARFENTANIL 01-12-88 10-28-88 53 FR 43684 10/28/1988 II

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE 10-14-88 04-13-89 54 FR 14797 4/13/1989 I

4-METHYLAMINOREX 10-14-88 04-13-89 54 FR 14799 4/13/1989 I

1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE 03-20-89 07-06-89 54 FR 28414 7/6/1989 I

N,N-DIMETHYLAMPHETAMINE** 08-02-89 54 FR 31815 8/2/1989 I

N,N-DIMETHYLAMPHETAMINE 08-02-89 02-02-90 55 FR 3586 2/2/1990 I


GLUTETHIMIDE 07-26-90 03-21-91 56 FR 11930 3/21/1991 III -> II

PROPYLHEXEDRINE 12-03-91 56 FR 61372 12/3/1991 V -> 0

METHCATHINONE* 05-01-92 57 FR 18824 5/1/1992 I

BUTORPHANOL, THEBAINE DERIVED 04-03-92 07-14-92 57 FR 31126 7/14/1992 II->0 Supersede

d 10/97

AMINOREX* 09-21-92 57 FR 43399 9/21/1992 I

ZOLPIDEM 11-24-92 02-05-93 58 FR 7186 2/5/1993 IV

CATHINONE 10-30-87 01-14-93 58 FR 4316 2/16/1993 I

2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET) 10-30-87 01-14-93 58 FR 4316 2/16/1993 I

ALPHA-ETHYLTRYPTAMINE* 03-12-93 58 FR 13533 3/12/1993 I

METHCATHINONE** 04-29-93 58 FR 25934 5/1/1993 I

LEVO-ALPHACETYLMETHADOL (LAAM) 04-28-93 08-18-93 58 FR 43795 8/18/1993 I -> II

AMINOREX** 08-24-93 58 FR 44611 9/21/1993 I

METHCATHINONE 04-28-93 10-15-93 58 FR 53404 10/15/1993 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE* 01-06-94 59 FR 00671 1/6/1994 I

ALPHA-ETHYLTRYPTAMINE** 03-07-94 59 FR 10720 3/12/1994 I



FINAL ORDER


AMINOREX 08-20-93 03-18-94 59 FR 12828 3/18/1994 I

ALPHA-ETHYLTRYPTAMINE 03-07-94 09-12-94 59 FR 46757 9/12/1994 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE** 12-21-94 59 FR 65710 1/6/1995 I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE 12-20-94 06-02-95 60 FR 28718 6/2/1995 I

REMIFENTANIL 09-16-96 11-05-96 61 FR 56893 11/5/1996 II

FENFLURAMINE 05-06-97 05-06-97 5/6/1997 IV -> 0

BUTORPHANOL 07-10-97 10-01-97 62 FR 51370 10/31/1997 IV

SIBUTRAMINE 12-08-97 02-11-98 63 FR 6862 2/11/1998 IV

MODAFINIL 04-14-98 01-27-99 64 FR 4050 1/27/1999 IV

DRONABINOL PRODUCT (MARINOL) 11-05-98 07-02-99 64 FR 35928 7/2/1999 II -> III

KETAMINE 04-09-99 07-13-99 64 FR 37673 8/12/1999 III

ZALEPLON 05-05-99 09-15-99 64 FR 49982 9/15/1999 IV

GAMMA HYDROXYBUTYRIC ACID (GHB) PL 106-172 03-13-00 65 FR 13235 3/13/2000 I

GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug PL 106-172 03-13-00 65 FR 13235 3/13/2000 III products

DIHYDROETORPHINE (thebaine derivative) 11-17-00 65 FR 69442 11/17/2000 clarification of CII control

DICHLORALPHENAZONE (chloral hydrate compound) 12-11-00 08-16-01 66 FR 42943 8/16/2001 clarification of CIV control

N-BENZYLPIPERAZINE (BZP) * 09-20-02 67 FR 59161 9/20/2002 I

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) * 09-20-02 67 FR 59161 9/20/2002 I

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-20-02 67 FR 59163 9/20/2002 I T-7) *

BUPRENORPHINE 03-21-02 10-07-02 67 FR 62354 10/7/2002 V --> III

ALPHA-METHYLTRYPTAMINE (AMT) * 04-04-03 68 FR 16427 4/4/2003 I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) * 04-04-03 68 FR 16427 4/4/2003 I

FENFLURAMINE 05-15-03 68 FR 26247 5/15/2003 IV Withdrew

97 proposed

rule

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-10-03 68 FR 53289 9/20/2003 I T-7) **

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) ** 09-10-03 68 FR 53289 9/20/2003 I

N-BENZYLPIPERAZINE (BZP) ** 09-10-03 68 FR 53289 9/20/2003 I

N-BENZYLPIPERAZINE (BZP) 09-08-03 03-18-04 69 FR 12794 3/18/2004 I

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- 09-08-03 03-18-04 69 FR 12794 3/18/2004 I T-7)

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) 09-08-03 03-18-04 69 FR 12794 3/19/2004 I --> 0

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) **

04-01-04 69 FR 17034 4/1/2004 I



FINAL ORDER


ALPHA-METHYLTRYPTAMINE (AMT) ** 04-01-04 69 FR 17034 4/1/2004 I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 09-29-04 69 FR 58050 9/29/2004 I

ALPHA-METHYLTRYPTAMINE (AMT) 09-29-04 69 FR 58050 9/29/2004 I

ZOPICLONE 02-14-05 04-04-05 70 FR 16935 4/4/2005 IV

PREGABALIN 05-12-05 07-28-05 70 FR 43633 7/28/2005 V


EMBUTRAMIDE 07-29-05 08-29-06 71 FR 51115 9/28/2006 III

LISDEXAMFETAMINE 02-22-07 05-03-07 72 FR 24532 6/4/2007 II

ORIPAVINE 09-24-07 72 FR 54208 9/24/2007 II

INDIPLON 01-31-08 01-31-08 1/31/2008 IV

LACOSAMIDE 03-10-09 05-21-09 74 FR 23789 6/22/2009 V

TAPENTADOL 02-17-09 05-21-09 74 FR 23790 6/22/2009 II

FOSPROPOFOL 07-23-09 10-06-09 74 FR 51234 11/5/2009 IV

19-NOR-4,9(10)-ANDROSTADIENEDIONE (estra-4,9(10)-diene- 04-25-08 12-04-09 74 FR 63603 1/4/2010 III 3,17-dione)

BOLDIONE (Androsta-1,4-diene-3,17-dione) 04-25-08 12-04-09 74 FR 63603 1/4/2010 III

DESOXYMETHYLTESTOSTERONE (17a-methyl-5a-androst-2- 04-25-08 12-04-09 74 FR 63603 1/4/2010 III en-17-ol, madol)

4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP) 04-09-08 06-29-10 75 FR 37296 8/30/2010 II

5-METHOXY-N,N-DIMETHYLTRYPTAMINE 08-21-09 12-20-10 75 FR 79296 1/19/2011 I

CP-47,497 * 03-01-11 76 FR 11075 3/1/2011 I

CP-47,497 C8 HOMOLOGUE * 03-01-11 76 FR 11075 3/1/2011 I

JWH-073 * 03-01-11 76 FR 11075 3/1/2011 I

JWH-018 * 03-01-11 76 FR 11075 3/1/2011 I

JWH-200 * 03-01-11 76 FR 11075 3/1/2011 I

3,4-METHYLENEDIOXYPYROVALERONE (MDPV)* 10-21-11 76 FR 65371 10/21/2011 I

4-METHYL-N-METHYLCATHINONE (MEPHEDRONE)* 10-21-11 76 FR 65371 10/21/2011 I

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 76 FR 65371 10/21/2011 I (METHYLONE)*

EZOGABINE 10-21-11 12-15-11 76 FR 77895 12/15/2011 V

CARISOPRODOL 11-17-09 12-12-11 76 FR 77330 1/11/2012 IV

JWH-018 ** 02-29-12 77 FR 12201 2/29/2012 I

JWH-073 ** 02-29-12 77 FR 12201 2/29/2012 I

CP-47,497 C8 HOMOLOGUE ** 02-29-12 77 FR 12201 2/29/2012 I

CP-47,497 ** 02-29-12 77 FR 12201 2/29/2012 I

JWH-200 ** 02-29-12 77 FR 12201 2/29/2012 I

METHASTERONE ( 2 ALPHA-17 ALPHA-DIMETHYL-5 ALPHA- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III ANDROSTAN-17BETA-OL-3-ONE)

PROSTANOZOL (17 BETA-HYDROXY-5 ALPHA- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III ANDROSTANO[3,2-C]PRYAZOLE



SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

3,4-METHYLENEDIOXY-N-METHYLCATHINONE (METHYLONE)

10-21-11 04-12-13 78 FR 21818 4/12/2013 I

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)*

05-16-13 78 FR 28735 5/16/2013 I

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR-144, XLR11)*

05-16-13 78 FR 28735 5/16/2013 I

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (APINACA, AKB48)*

05-16-13 78 FR 28735 5/16/2013 I

LORCASERIN 12-19-12 05-08-13 78 FR 26701 6/7/2013 IV

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) ETHANAMINE (25I-NBOMe)*

11-15-13 78 FR 68716 11/15/2013 I

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) ETHANAMINE (25C-NBOMe)*

11-15-13 78 FR 68716 11/15/2013 I

2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) ETHANAMINE (25B-NBOMe)*

11-15-13 78 FR 68716 11/15/2013 I

PERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2-DIHYDROPYRIDIN-3-YL)BENZONITRILE ]

10-22-13 12-02-13 78 FR 72013 1/2/2014 III

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE ( 5-FLUORO-PB22; 5FPB22)*

02-10-14 79 FR 7577 2/10/2014 I

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB22; QUPIC)*

02-10-14 79 FR 7577 2/10/2014 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE FUBINACA)*

(AB-02-10-14 79 FR 7577 2/10/2014 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)*

02-10-14 79 FR 7577 2/10/2014 I

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP)* 03-07-14 79 FR 12938 3/7/2014 I

PENTYLONE* 03-07-14 79 FR 12938 3/7/2014 I

PENTEDRONE* 03-07-14 79 FR 12938 3/7/2014 I

NAPHYRONE* 03-07-14 79 FR 12938 3/7/2014 I

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP)* 03-07-14 79 FR 12938 3/7/2014 I

4-METHYL-N-ETHYLCATHINONE (4-MEC)* 03-07-14 79 FR 12938 3/7/2014 I

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-MePPP)*

03-07-14 79 FR 12938 3/7/2014 I



BUTYLONE* 03-07-14 79 FR 12938 3/7/2014 I

ALFAXALONE (5-PREGNAN-3-OL-11,20-DIONE) 03-25-13 02-27-14 79 FR 10985 3/31/2014 IV

TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXANOL)

11-04-13 07-02-14 79 FR 37623 8/18/2014 IV

SUVOREXANT 02-13-14 08-28-14 79 FR 52143 9/29/2014 IV

HYDROCODONE COMBINATION PRODUCTS 02-27-14 08-22-14 79 FR 49661 10/6/2014 III->II

NALOXEGEL 10-29-14 01-23-15 80 FR 3468 1/23/2015 II->0



SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1-YL)METHANONE (THJ-2201)*

01-30-15 80 FR 5042 1/30/2015 I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (AB-PINACA)*

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)1-(CYCLOHEXYLMETHYL) 1H-INDAZOLE-3-CARBOXAMIDE (AB-CHMINACA)*

ACETYL FENTANYL* (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

ELUXADOLINE

N-(1-AMINO-3,3DIMETHYL-1-OXOBUTAN-2-YL)1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3CARBOXAMIDE (MAB-CHMINACA)*

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB-FUBINACA)**

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE ( 5-FLUORO-PB22; 5FPB22)**

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB22; QUPIC)**

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)**

3-FLUORO-N-METHYLCATHINONE (3-FMC)**

PENTYLONE**

PENTEDRONE**

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP)**

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP)**

4-METHYL-N-ETHYLCATHINONE (4-MEC)**

4-FLUORO-N-METHYLCATHINONE (4-FMC)**

BUTYLONE**

NAPHYRONE**

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-MePPP)**

BRIVARACETAM (BRV; UCB-34714; BRIVIACT)

BUTYRYL FENTANYL*

BETA-HYDROXYTHIOFENTANYL*

3,4-DICHLORO-N-[(1-DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE) (AH-7921)

THIAFENTANIL

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB-22; QUPIC)

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

08-11-15

01-30-15

01-30-15

07-17-15

11-12-15

02-05-16

02-05-16

02-05-16

02-05-16

02-05-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

03-04-16

05-12-16

05-12-16

05-12-16

04-14-16

08-26-16

09-06-16

09-06-16

80 FR 5042

80 FR 5042

80 FR 42381

80 FR 69861

81 FR 6171

81 FR 6175

81 FR 6175

81 FR 6175

81 FR 6175

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 11429

81 FR 29487

81 FR 29492

81 FR 29492

81 FR 22023

81 FR 58834

81 FR 61130

81 FR 61130

1/30/2015

1/30/2015

7/17/2015

12/17/2015

2/5/2016

2/5/2016

2/5/2016

2/5/2016

2/5/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

3/4/2016

5/12/2016

5/12/2016

5/12/2016

5/15/2016

8/26/2016

9/6/2016

9/6/2016

I

I

I

IV

I

I

I

I

I

I

I

I

I

I

I

I

I

I

I

V

I

I

I

II

I

I



FINAL ORDER

SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FEDERAL

REGISTER

CITATION EFFECTIVE

DATE

CSA

SCHEDULE

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB-FUBINACA)

09-06-16 81 FR 61130 9/6/2016 I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

09-06-16 81 FR 61130 9/6/2016 I

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N-METHYLBENZAMIDE (U-47700)*

11-14-16 81 FR 79389 11/14/2016 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2-CARBOXAMIDE (FURANYL FENTANYL) *

11-29-16 81 FR 85873 11/29/2016 I


NAPHYRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I


4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4-MePPP)

03-04-16 03-01-17 82 FR 12171 3/1/2017 I

BUTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

PENTEDRONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

PENTYLONE 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

ALPHA-PYRROLIDINOPENTIOPHENONE (-PVP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

4-METHYL-N-ETHYLCATHINONE (4-MEC) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

ALPHA-PYRROLIDINOBUTIOPHENONE (-PBP) 03-04-16 03-01-17 82 FR 12171 3/1/2017 I

DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMIN.

03-23-17 82 FR 14815 3/23/2017 II

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)1H-INDAZOLE-3-CARBOXAMIDE (ADBFUBINACA)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB-CHMICA)*

04-10-17 82 FR 17119 4/10/2017 I

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5FAPINACA, 5FAKB48)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB)*

04-10-17 82 FR 17119 4/10/2017 I

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBFUBINACA)*

04-10-17 82 FR 17119 4/10/2017 I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)*

05-03-17 82 FR 20544 5/3/2017 I

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

06-07-17 82 FR 26349 6/7/2017 I

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACRYLAMIDE)*

07-14-17 82 FR 32453 7/14/2017 I

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))*

10-26-17 82 FR 49504 10/26/2017 I


Page 10 of 11 01-Mar-18

SUBSTANCE



PROPOSAL

PUBLICATION

DATE PUBLICATION

DATE

FINAL

FEDERAL

REGISTER

CITATION

ORDER

EFFECTIVE

DATE

CSA

SCHEDULE

TETRAHYDROFURANYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)*

10-26-17 82 FR 49504 10/26/2017 I

METHOXYACETYL FENTANYL (2-METHOXY-N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)*

10-26-17 82 FR 49504 10/26/2017 I

FUBAMB, MMB FUBINACA (2-(1-(4-FLUOROBENZYL)-1HINDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE*

11-03-17 82 FR 51154 11/3/2017 I

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)*

01-04-18 83 FR 469 1/4/2018 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE (VALERYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)*

02-01-18 83 FR 4580 2/1/2018 I

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1-PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)*

02-01-18 83 FR 4580 2/1/2018 I

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 CFR 1308.11(h)*

02-06-18 83 FR 5188 2/6/2018 I


Page 11 of 11 01-Mar-18


Alphabetical O

rder


- Alphabetical Order -

DEA CSA

SUBSTANCE NUMBER SCH NARC OTHER NAMES

-6-bromo-androsta-1,4-diene-3,17-dione 4000 III N

[3,2-c]-furazan-5-androstan-17-ol 4000 III N

[3,2-c]pyrazole-androst-4-en-17-ol 4000 III N

1-(1-Phenylcyclohexyl)pyrrolidine 7458 I N PCPy, PHP, rolicyclidine

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 I Y PEPAP, synthetic heroin

1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I N TCP, tenocyclidine

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I N TCPy

13Beta-ethyl-17beta-hydroxygon-4-en-3-one 4000 III N

17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha- 4000 III N

androstane

17Alpha-methyl-3beta,17beta-dihydroxy-5alpha- 4000 III N

androstane

17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene 4000 III N

17Alpha-methyl-4-hydroxynandrolone (17alpha-methyl- 4000 III N

4-hydroxy-17beta-hydroxyestr-4-en-3-one)

17Alpha-methyl-delta1-dihydrotestosterone (17beta- 4000 III N 17-Alpha-methyl-1-testosterone hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one)

17-Methyl-5-androstan-17-ol 4000 III N

17-methyl-androst-2-ene-3,17-diol 4000 III N

17-methyl-androsta-1,4-diene-3,17-diol 4000 III N

17-Methyl-androstan-3-hydroxyimine-17-ol 4000 III N

17-Hydroxy-androstano[2,3-d]isoxazole 4000 III N

17-Hydroxy-androstano[3,2-c]isoxazole 4000 III N

18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one 4000 III N

19-Nor-4,9(10)-androstadienedione 4000 III N

19-Nor-4-androstenediol (3beta,17beta-dihydroxyestr-4- 4000 III N

ene; 3alpha,17beta-dihydroxyestr-4-ene)

19-Nor-4-androstenedione (estr-4-en-3,17-dione) 4000 III N

19-Nor-5-androstenediol (3beta,17beta-dihydroxyestr-5- 4000 III N

ene; 3alpha,17beta-dihydroxyestr-5-ene)

19-Nor-5-androstenedione (estr-5-en-3,17-dione) 4000 III N

1-Androstenediol (3beta,17beta-dihydroxy-5alpha- 4000 III N

androst-1-ene; 3alpha,17beta-dihydroxy-5alpha-androst-1-ene)

Abbreviations: "NARC"= Narcotic, "CSA SCH"= CSA Schedule

Controlled Substances - Alphabetical Order


DEA CSA


1-Androstenedione (5alpha-androst-1-en-3,17-dione) 4000 III N

1-Methyl-4-phenyl-4-propionoxypiperidine 9661 I Y MPPP, synthetic heroin

1-Phenylcyclohexylamine 7460 II N PCP precursor

1-Piperidinocyclohexanecarbonitrile 8603 II N PCC, PCP precursor

2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 7021 I N FUBAMB, MMB FUBINACA, AMBFUBINACA methylbutanoate

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- 7524 I N 2C-P P)

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) 7509 I N 2C-E (Positional Isomer: 2,5-Dimethoxy-3,4-dimethylphenethylamine (2C-G))

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) 7508 I N 2C-D

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) 7521 I N 2C-N

2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I N 2C-H

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe, 2C-B-NBOMe, 25B, Cimbi-36 ethanamine (25B-NBOMe)

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) 7519 I N 2C-C

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7537 I N 25C-NBOMe, 2C-C-NBOMe, 25C, Cimbi-82 ethanamine (25C-NBOMe)

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C- 7385 I N 2C-T-2 T-2 )

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) 7518 I N 2C-I

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7538 I N 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 ethanamine (25I-NBOMe)

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (Positional Isomer: 2,5-Dimethoxy-4-(2C-T-4 ) ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T- 7348 I N 2C-T-7 (Positional Isomer: 2,5-Dimethoxy-4-7) ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET

2,5-Dimethoxyamphetamine 7396 I N DMA, 2,5-DMA

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

2,17-dimethyl-17-hydroxy-5-androstan-3-one 4000 III N

2,3-epithio-17-methyl-5-androstan-17-ol 4000 III N

3,4,5-Trimethoxyamphetamine 7390 I N TMA (Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA-5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

3,4-Methylenedioxyamphetamine 7400 I N MDA, Love Drug

3,4-Methylenedioxymethamphetamine 7405 I N MDMA, Ecstasy, XTC

3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-ethyl MDA, MDE, MDEA

3Alpha,17beta-dihydroxy-5alpha-androstane 4000 III N

3Beta,17beta-dihydroxy-5alpha-androstane 4000 III N

3-Fluoro-N-methylcathinone (3-FMC) 1233 I N 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) (Positional isomer: 2-FMC)




DEA CSA


3-Methylfentanyl 9813 I Y China White, fentanyl

3-Methylthiofentanyl 9833 I Y China White, fentanyl

3-hydroxy-estra-4,9,11-trien-17-one 4000 III N

4-Androstenediol (3beta,17beta-dihydroxy-androst-4- 4000 III N 4-AD ene)

4-Androstenedione (androst-4-en-3,17-dione) 4000 III N

4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II N ANPP, Despropionyl fentanyl

4-Bromo-2,5-dimethoxyamphetamine 7391 I N DOB, 4-bromo-DMA

4-Bromo-2,5-dimethoxyphenethylamine 7392 I N 2C-B, Nexus, has been sold as Ecstasy, i.e. MDMA

4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one 4000 III N

4-chloro-17-methyl-17-hydroxy-androst-4-ene-3,11- 4000 III N

dione

4-chloro-17-methyl-androst-4-ene-3,17-diol 4000 III N

4-chloro-17-methyl-androsta-1,4-diene-3,17-diol 4000 III N

4-Dihydrotestosterone (17beta-hydroxyandrostan-3- 4000 III N Anabolex, Andractim, Pesomax, Stanolone one)

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- 9824 I Y Para-fluoroisobutyryl fentanyl phenethylpiperidin-4-yl)isobutyramide)

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1-one) (Positional isomer: 2-FMC)

4-Hydroxy-19-nortestosterone (4,17beta-dihydroxyestr- 4000 III N

4-en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5-androstan-17-ol

4-Hydroxytestosterone (4,17beta-dihydroxyandrost-4- 4000 III N

en-3-one)

4-Methoxyamphetamine 7411 I N PMA

4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM, STP (Positional Isomer: 2,5-Dimethoxy-3,4-dimethylphenethylamine (2C-G))

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) 7498 I N MePPP, 4-methyl--pyrrolidinopropiophenone, 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one)

4-Methylaminorex (cis isomer) 1590 I N U4Euh, McN-422

4-Methyl-N-ethylcathinone (4-MEC) 1249 I N 2-(ethylamino)-1-(4-methylphenyl)propan-1-one)(Positional Isomers:3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4-dimethylmethcathinone(3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

5-Androstenediol (3beta,17beta-dihydroxy-androst-5- 4000 III N

ene)

5-Androstenedione (androst-5-en-3,17-dione) 4000 III N




SUBSTANCE

DEA

NUMBER

CSA

SCH NARC OTHER NAMES

5FADB; 5FMDMBPINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)

7034 I N 5F-ADB, 5F-MDMB-PINACA

5FAMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- 7033 I N 5F-AMB carboxamido)-3-methylbutanoate)

5FAPINACA, 5FAKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA, 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144, XLR-11 and XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 7225 I N 5-Fluoro-PB-22; 5F-PB-22 carboxylate)

5-Methoxy-3,4-methylenedioxyamphetamine 7401 I N MMDA

5-Methoxy-N,N-diisopropyltryptamine 7439 I N 5-MeO-DIPT (Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5-MeO-DPT))

5-Methoxy-N-N-dimethyltryptamine 7431 I N 5-MeO-DMT (Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4-MeO-DMT))

5-Androstan-3,6,17-trione 4000 III N

6-bromo-androstan-3,17-dione 4000 III N

6-Methyl-androst-4-ene-3,17-dione 4000 III N

AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I N AB-CHMINACA oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

AB-PINACA (N-(1-amino-3-methyl- 7023 I N AB-PINACA 1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)

Acetorphine 9319 I Y

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9821 I Y

phenylacetamide)

Acetyl-alpha-methylfentanyl 9815 I Y

Acetyldihydrocodeine 9051 I Y Acetylcodone

Acetylmethadol 9601 I Y Methadyl acetate

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9811 I Y Acryloylfentanyl phenylacrylamide)

ADBFUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I N ADB-PINACA yl)-1-pentyl-1H-indazole-3-carboxamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y AH-7921 dimethylamino)cyclohexylmethyl]benzamide))

Alfaxalone 2731 IV N Alfaxan, 5-pregnan-3-ol-11,20-dione

Alfentanil 9737 II Y Alfenta

Allylprodine 9602 I Y

Alphacetylmethadol except levo-alphacetylmethadol 9603 I Y




DEA CSA


Alpha-ethyltryptamine 7249 I N ET, Trip

Alphameprodine 9604 I Y

Alphamethadol 9605 I Y

Alpha-methylfentanyl 9814 I Y China White, fentanyl

Alpha-methylthiofentanyl 9832 I Y China White, fentanyl

Alpha-methyltryptamine 7432 I N AMT (Positional Isomer: N-Methyltryptamine)

Alphaprodine 9010 II Y Nisentil

alpha-pyrrolidinobutiophenone (-PBP) 7546 I N 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one)

alpha-pyrrolidinopentiophenone (-PVP) 7545 I N -pyrrolidinovalerophenone, 1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one)(Positional isomers: 4-methyl--pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2-(piperidin-1-yl)butan-1-one)

Alprazolam 2882 IV N Xanax

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) 7201 I N AM2201

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) 7694 I N AM-694

Aminorex 1585 I N has been sold as methamphetamine

Amobarbital 2125 II N Amytal, Tuinal

Amobarbital & noncontrolled active ingred. 2126 III N

Amobarbital suppository dosage form 2126 III N

Amphetamine 1100 II N Dexedrine, Adderall, Obetrol

Anabolic steroids 4000 III N "Body Building" drugs

Androstanedione (5alpha-androstan-3,17-dione) 4000 III N

Anileridine 9020 II Y Leritine

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- 7048 I N APINACA and AKB48 indazole-3-carboxamide

Aprobarbital 2100 III N Alurate

Barbital 2145 IV N Veronal, Plexonal, barbitone

Barbituric acid derivative 2100 III N Barbiturates not specifically listed

Benzethidine 9606 I Y

Benzphetamine 1228 III N Didrex, Inapetyl

Benzylmorphine 9052 I Y

Betacetylmethadol 9607 I Y

Beta-hydroxy-3-methylfentanyl 9831 I Y China White, fentanyl

Beta-hydroxyfentanyl 9830 I Y China White, fentanyl

Beta-hydroxythiofentanyl 9836 I Y N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide

Betameprodine 9608 I Y

Betamethadol 9609 I Y




SUBSTANCE

DEA

NUMBER

CSA


Betaprodine 9611 I Y

Bezitramide 9800 II Y Burgodin

Bolasterone (7alpha,17alpha-dimethyl-17beta- 4000 III N

hydroxyandrost-4-en-3-one)

Boldenone (17beta-hydroxyandrost-1,4-diene-3-one) 4000 III N Equipoise, Parenabol, Vebonol, dehydrotestosterone

Boldione 4000 III N

Brivaracetam 2710 V N BRV, UCB-34714, Briviact, ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide)

Bromazepam 2748 IV N Lexotan, Lexatin, Lexotanil

Bufotenine 7433 I N Mappine, N,N-dimethylserotonin

Buprenorphine 9064 III Y Buprenex, Temgesic, Subutex, Suboxone

Butabarbital (secbutabarbital) 2100 III N Butisol, Butibel

Butalbital 2100 III N Fiorinal, Butalbital with aspirin

Butobarbital (butethal) 2100 III N Soneryl (UK)

Butorphanol 9720 IV N Stadol, Stadol NS, Torbugesic, Torbutrol

Butylone 7541 I N bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one) (Positional Isomers: -ethylone (bk-MDEA; MDEC), dimethylone (bk-MDDMA; MDDMC))

Butyryl Fentanyl 9822 I Y N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide

Calusterone (7beta,17alpha-dimethyl-17beta- 4000 III N Methosarb hydroxyandrost-4-en-3-one)

Camazepam 2749 IV N Albego, Limpidon, Paxor

Carfentanil 9743 II Y Wildnil

Carisoprodol 8192 IV N Soma

Cathine 1230 IV N Constituent of "Khat" plant, (+)-norpseudoephedrine

Cathinone 1235 I N Constituent of "Khat" plant

Chloral betaine 2460 IV N Beta Chlor

Chloral hydrate 2465 IV N Noctec

Chlordiazepoxide 2744 IV N Librium, Libritabs, Limbitrol, SK-Lygen

Chlorhexadol 2510 III N Mechloral, Mecoral, Medodorm, Chloralodol

Chlorphentermine 1645 III N Pre-Sate, Lucofen, Apsedon, Desopimon

Clobazam 2751 IV N Urbadan, Urbanyl

Clonazepam 2737 IV N Klonopin, Clonopin

Clonitazene 9612 I Y

Clorazepate 2768 IV N Tranxene

Clortermine 1647 III N Voranil

Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one) 4000 III N Alfa-Trofodermin, Clostene, 4-chlorotestosterone

Clotiazepam 2752 IV N Trecalmo, Rize, Clozan, Veratran




DEA CSA


Cloxazolam 2753 IV N Akton, Lubalix, Olcadil, Sepazon

Coca Leaves 9040 II Y

Cocaine 9041 II Y Methyl benzoylecgonine, Crack

Codeine 9050 II Y Morphine methyl ester, methyl morphine

Codeine & isoquinoline alkaloid 90 mg/du 9803 III Y Codeine with papaverine or noscapine

Codeine combination product 90 mg/du 9804 III Y Empirin,Fiorinal,Tylenol,ASA or APAP w/codeine

Codeine methylbromide 9070 I Y

Codeine preparations - 200 mg/(100 ml or 100 gm) V Y Cosanyl,Robitussin A-C,Cheracol,Cerose,Pediacof

Codeine-N-oxide 9053 I Y

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- 7297 I N CP-47,497 hydroxycyclohexyl-phenol)

CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2- 7298 I N CP-47,497 C8 Homologue [(1R,3S)3-hydroxycyclohexyl-phenol)

Cyclopentyl fentanyl 9847 I Y N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

Cyclopropyl Fentanyl 9845 I Y N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

Cyprenorphine 9054 I Y

Dehydrochloromethyltestosterone (4-chloro-17beta- 4000 III N Oral-Turinabol hydroxy-17alpha-methylandrost-1,4-dien-3-one)

Delorazepam 2754 IV N

Delta1-dihydrotestosterone (17beta-hydroxy-5alpha- 4000 III N 1-Testosterone androst-1-en-3-one)

Desomorphine 9055 I Y

Desoxymethyltestosterone 4000 III N

Dexfenfluramine 1670 IV N Redux

Dextromoramide 9613 I Y Palfium, Jetrium, Narcolo

Dextropropoxyphene dosage forms 9278 IV Y Darvon, propoxyphene, Darvocet, Propacet

Dextropropoxyphene, bulk (non-dosage forms) 9273 II Y Propoxyphene

Diampromide 9615 I Y

Diazepam 2765 IV N Valium, Diastat

Dichloralphenazone 2467 IV N Midrin, dichloralantipyrine

Diethylpropion 1610 IV N Tenuate, Tepanil

Diethylthiambutene 9616 I Y

Diethyltryptamine 7434 I N DET, N,N-Diethyltryptamine (Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

Difenoxin 9168 I Y Lyspafen

Difenoxin 1 mg/25 ug AtSO4/du 9167 IV Y Motofen

Difenoxin preparations - 0.5 mg/25 ug AtSO4/du V Y Motofen

Dihydrocodeine 9120 II Y Didrate, Parzone




SUBSTANCE

DEA

NUMBER

CSA


Dihydrocodeine combination product 90 mg/du 9807 III Y Synalgos-DC, Compal

Dihydrocodeine preparations 100mg/(100 ml or 100 V Y Cophene-S, various others gm)

Dihydroetorphine 9334 II Y DHE

Dihydromorphine 9145 I Y

Dimenoxadol 9617 I Y

Dimepheptanol 9618 I Y

Dimethylthiambutene 9619 I Y

Dimethyltryptamine 7435 I N DMT

Dioxaphetyl butyrate 9621 I Y

Diphenoxylate 9170 II Y

Diphenoxylate preparations 2.5 mg/25 ug AtSO4 V Y Lomotil, Logen

Dipipanone 9622 I Y Dipipan, phenylpiperone HCl, Diconal, Wellconal

Dronabinol (synthetic) in sesame oil in soft gelatin 7369 III N Marinol, synthetic THC in sesame oil/soft gelatin as capsule as approved by FDA approved by FDA

Dronabinol in an oral solution in a drug product 7365 II N Syndros approved for marketing by the U.S. Food and Drug Administration

Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha- 4000 III N Drolban, Masterid, Permastril androstan-3-one)

Drotebanol 9335 I Y Metebanyl, oxymethebanol

Ecgonine 9180 II Y Cocaine precursor, in Coca leaves

Eluxadoline 9725 IV N VIBERZI

Embutramide 2020 III N Tributane

Estazolam 2756 IV N ProSom, Domnamid, Eurodin, Nuctalon

Estra-4,9,11-triene-3,17-dione 4000 III N

Ethchlorvynol 2540 IV N Placidyl

Ethinamate 2545 IV N Valmid, Valamin

Ethyl loflazepate 2758 IV N

Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene) 4000 III N Maxibolin, Orabolin, Durabolin-O, Duraboral

Ethylmethylthiambutene 9623 I Y

Ethylmorphine 9190 II Y Dionin

Ethylmorphine combination product 15 mg/du 9808 III Y

Ethylmorphine preparations 100 mg/(100 ml or 100 gm) V Y

Etonitazene 9624 I Y

Etorphine (except HCl) 9056 I Y

Etorphine HCl 9059 II Y M 99

Etoxeridine 9625 I Y

Ezogabine 2779 V N Potiga




SUBSTANCE

DEA

NUMBER

CSA


Fencamfamin 1760 IV N Reactivan

Fenethylline 1503 I N Captagon,amfetyline,ethyltheophylline amphetamine

Fenfluramine 1670 IV N Pondimin, Ponderal

Fenproporex 1575 IV N Gacilin, Solvolip

Fentanyl 9801 II Y Duragesic, Oralet, Actiq, Sublimaze, Innovar

Fentanyl related-compounds as defined in 21 CFR 9850 I Y

1308.11(h)

Fludiazepam 2759 IV N

Flunitrazepam 2763 IV N Rohypnol, Narcozep, Darkene, Roipnol

Fluoxymesterone (9-fluoro-17alpha-methyl- 4000 III N Anadroid-F, Halotestin, Ora-Testryl 11beta,17beta-dihydroxyandrost-4-en-3-one)

Flurazepam 2767 IV N Dalmane

Formebolone (2-formyl-17alpha-methyl- 4000 III N Esiclene, Hubernol 11alpha,17beta-dihydroxyandrost-1,4-dien-3-one)

Fospropofol 2138 IV N Lusedra

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9834 I Y

phenylfuran-2-carboxamide)

Furazabol (17alpha-methyl-17beta- 4000 III N Frazalon, Miotolon, Qu Zhi Shu hydroxyandrostano[2,3-c]-furazan)

Furethidine 9626 I Y

Gamma Hydroxybutyric Acid 2010 I N GHB, gamma hydroxybutyrate, sodium oxybate

Gamma Hydroxybutyric Acid preparations 2012 III N Xyrem

Glutethimide 2550 II N Doriden, Dorimide

Halazepam 2762 IV N Paxipam

Haloxazolam 2771 IV N

Heroin 9200 I Y Diacetylmorphine, diamorphine

Hydrocodone 9193 II Y dihydrocodeinone

Hydromorphinol 9301 I Y

Hydromorphone 9150 II Y Dilaudid, dihydromorphinone

Hydroxypethidine 9627 I Y

Ibogaine 7260 I N Constituent of "Tabernanthe iboga" plant

Isobutyryl fentanyl 9827 I Y N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide

Isomethadone 9226 II Y Isoamidone

JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I N JWH-018 and AM-678 naphthoyl)indole)

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) 7019 I N JWH-019

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) 7173 I N JWH-073

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) 7081 I N JWH-081

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) 7122 I N JWH-122




DEA CSA


JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I N JWH-200 naphthoyl)indole)

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) 7203 I N JWH-203

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) 6250 I N JWH-250

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) 7398 I N JWH-398

Ketamine 7285 III N Ketaset, Ketalar, Special K, K

Ketazolam 2772 IV N Anxon, Loftran, Solatran, Contamex

Ketobemidone 9628 I Y Cliradon

Lacosamide 2746 V N Vimpat

Levo-alphacetylmethadol 9648 II Y LAAM, long acting methadone, levomethadyl acetate

Levomethorphan 9210 II Y

Levomoramide 9629 I Y

Levophenacylmorphan 9631 I Y

Levorphanol 9220 II Y Levo-Dromoran

Lisdexamfetamine 1205 II N Vyvanse

Loprazolam 2773 IV N

Lorazepam 2885 IV N Ativan

Lorcaserin 1625 IV N Belviq

Lormetazepam 2774 IV N Noctamid

Lysergic acid 7300 III N LSD precursor

Lysergic acid amide 7310 III N LSD precursor

Lysergic acid diethylamide 7315 I N LSD, lysergide

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I N MAB-CHMINACA and ADB-CHMINACA oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

Marihuana 7360 I N Cannabis, marijuana

Marihuana Extract 7350 I N

Mazindol 1605 IV N Sanorex, Mazanor

MDMBCHMICA, MMBCHMINACA (Methyl 2-(1- 7042 I N MDMB-CHMICA, MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)

MDMBFUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate)

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N MDPV

Mebutamate 2800 IV N Capla

Mecloqualone 2572 I N Nubarene

Medazepam 2836 IV N Nobrium

Mefenorex 1580 IV N Anorexic, Amexate, Doracil, Pondinil

Meperidine 9230 II Y Demerol, Mepergan, pethidine



01-Mar-18 Page 10 of 16

SUBSTANCE

DEA

NUMBER

CSA


Meperidine intermediate-A 9232 II Y Meperidine precursor

Meperidine intermediate-B 9233 II Y Meperidine precursor, normeperidine

Meperidine intermediate-C 9234 II Y Meperidine precursor

Mephedrone

scheduling actions controlled substances regulated chemicals

Documents